JP2024507550A5 - - Google Patents

Info

Publication number
JP2024507550A5
JP2024507550A5 JP2023550695A JP2023550695A JP2024507550A5 JP 2024507550 A5 JP2024507550 A5 JP 2024507550A5 JP 2023550695 A JP2023550695 A JP 2023550695A JP 2023550695 A JP2023550695 A JP 2023550695A JP 2024507550 A5 JP2024507550 A5 JP 2024507550A5
Authority
JP
Japan
Prior art keywords
alkyl
pharmaceutically acceptable
acceptable salt
compound according
aryl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2023550695A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024507550A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/017134 external-priority patent/WO2022182604A1/en
Publication of JP2024507550A publication Critical patent/JP2024507550A/ja
Publication of JP2024507550A5 publication Critical patent/JP2024507550A5/ja
Withdrawn legal-status Critical Current

Links

JP2023550695A 2021-02-23 2022-02-21 Ｈｉｖ療法に有用な化合物 Withdrawn JP2024507550A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163152356P 2021-02-23 2021-02-23
US63/152,356 2021-02-23
PCT/US2022/017134 WO2022182604A1 (en) 2021-02-23 2022-02-21 Compounds useful in hiv treatment

Publications (2)

Publication Number Publication Date
JP2024507550A JP2024507550A (ja) 2024-02-20
JP2024507550A5 true JP2024507550A5 (https=) 2025-03-05

Family

ID=80685329

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023550695A Withdrawn JP2024507550A (ja) 2021-02-23 2022-02-21 Ｈｉｖ療法に有用な化合物

Country Status (4)

Country Link
US (1) US20240182510A1 (https=)
EP (1) EP4298105A1 (https=)
JP (1) JP2024507550A (https=)
WO (1) WO2022182604A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4358968A4 (en) * 2021-06-22 2025-05-07 Rome Therapeutics, Inc. 4-ETHINYL-3-HYDROXY-TETRAHYDROFURANYL ADENINE PHOSPHORAMIDATE AND RELATED COMPOUNDS AND THEIR USE IN THE TREATMENT OF MEDICAL DISEASES

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4107288A (en) 1974-09-18 1978-08-15 Pharmaceutical Society Of Victoria Injectable compositions, nanoparticles useful therein, and process of manufacturing same
US5145684A (en) 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
EP1378509A4 (en) 2001-03-19 2009-03-25 Ono Pharmaceutical Co DRUGS WITH TRIAZASPIRO ç5.5] UNDECANDERIVATES AS ACTIVE SUBSTANCE
CA2502109C (en) 2004-03-24 2010-02-23 Yamasa Corporation 4'-c-substituted-2-haloadenosine derivative
CN104640444B (zh) * 2012-06-16 2016-12-14 河南美泰宝生物制药有限公司 双肝脏靶向氨基磷酸酯和氨基膦酸酯前药
CN113811360A (zh) * 2019-03-06 2021-12-17 葛兰素史密斯克莱知识产权（第2 号）有限公司 用于hiv治疗的化合物
WO2021188959A1 (en) * 2020-03-20 2021-09-23 Gilead Sciences, Inc. Prodrugs of 4'-c-substituted-2-halo-2'-deoxyadenosine nucleosides and methods of making and using the same

Similar Documents

Publication Publication Date Title
JP2024001048A5 (https=)
JP3133345B2 (ja) Ｈｉｖに対して活性な連結環状ポリアミン
JP2024508755A5 (https=)
JP2024050527A5 (https=)
JP2024543982A5 (https=)
JP2023531311A5 (https=)
JP2020169171A5 (https=)
JP2022547558A5 (https=)
JP2022505841A5 (https=)
JP2020534263A5 (https=)
JP2011509309A5 (https=)
JP2020533352A5 (https=)
JPH07108855B2 (ja) 循環器治療薬として有用な酸化窒素―第一級アミン安定化コンプレックス
JP2022505597A5 (https=)
JP2001526269A5 (https=)
JP2011509302A5 (https=)
JP2011509301A5 (https=)
JPH06500078A (ja) Ｔｎｆ抑制剤
JP2022505989A5 (https=)
JP2002537258A5 (https=)
JP2024503723A5 (https=)
JP2020111571A5 (https=)
JP2007529426A5 (https=)
HUP0203121A2 (hu) Szubsztituált benzimidazolokat tartalmazó gyógyszerkészítmény és alkalmazása
JP2024546138A5 (https=)